An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62.
Sign Up to like & getrecommendations! Published in 2020 at "Chemico-biological interactions"
DOI: 10.1016/j.cbi.2020.109168
Abstract: Warfarin is the most commonly used anticoagulant in the clinical treatment of thromboembolic diseases. The dose of warfarin varies significantly within populations, and the dose is closely related to the genetic polymorphisms of the CYP2C9… read more here.
Keywords: functional evaluation; evaluation novel; identification functional; cyp2c9 ... See more keywords